Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease, a study published today in the British Medical Journal ...
Mar 28, 2012
0
0
More than 100 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at "warp speed"—possibly by the end of the year—but the bar set for an effective, long-lasting ...
Sep 10, 2020
0
14
When the flu virus begins mixing with the coronavirus this fall, the resulting double whammy of respiratory disease threatens to overwhelm doctors and hospitals, officials fear.
Aug 26, 2020
0
12
AIDS research has investigated many strategies to tackle the HIV virus. Now, a new type of vaccine developed within the EU-funded project EuroNeut-41, targets an HIV envelope protein called the gp41. The protein is directly ...
Nov 27, 2013
0
0
In an approach with the potential to aid therapeutic vaccine development, Whitehead Institute scientists have shown that enzymatically modified antibodies can be used to generate highly targeted, potent responses from cells ...
Jan 7, 2013
0
0
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
Nov 3, 2022
0
23
Despite a daunting more than 130 million cases of SARS-CoV-2 infections to date worldwide, another global pathogen—the Aedes mosquito-borne dengue virus—saw a record number of over 400 million cases in 2019. But vaccine ...
May 24, 2021
0
28
Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective, according to a comprehensive new analysis to be released on Thursday, Nov. 10.
Nov 10, 2011
0
0
Saint Louis University Center for Vaccine Development researchers have identified a potential new target for vaccines that activates a part of the immune system not previously known to be protective against Chagas disease, ...
Oct 25, 2016
0
17
Researchers at the University of Florida College of Veterinary Medicine say proteins common to multiple strains of Anaplasma marginale, a tick-borne pathogen that costs the U.S. cattle industry millions of dollars annually ...
Jul 14, 2011
0
0
